Updated Jul 16, 2026
Chen Shu-Chih has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Chen Shu-Chih is identified in SEC filings as affiliated with Atossa Therapeutics, Inc. as of May 14, 2026. Atossa Therapeutics is a publicly traded biotechnology company. The provided SEC context does not specify Chen Shu-Chih's exact role or title within the company, only noting an affiliation in the 2026 filings.
| Role | Insider |
|---|---|
| Notability | 45/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-14 | ATOS | ATOSSA THERAPEUTICS, INC. | A — Grant or award | 10.0K | $0.00 |
Chen Shu-Chih is identified in SEC filings as affiliated with Atossa Therapeutics, Inc. as of May 14, 2026. Atossa Therapeutics is a publicly traded biotechnology company. The provided SEC context does not specify Chen Shu-Chih's exact role or title within the company, only noting an affiliation in the 2026 filings.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Chen Shu-Chih profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.